Anna Myriam Perrone

48PUBLICATIONS
258CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methodsElectrical energy generation (incl. renewables, excl. photovoltaics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Apr 14, 2026
Impact of Facility Volume on Therapy and Survival for Endometrial Cancer: A Retrospective Multicenter Study.

Vincenzo Dario Mandato, Anna Myriam Perrone, Debora Pirillo

|Aug 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

|Jul 12, 2025
Impact of a Surgical Approach on Endometrial Cancer Survival According to ESMO/ESGO Risk Classification: A Retrospective Multicenter Study in the Northern Italian Region.

Vincenzo Dario Mandato, Anna Myriam Perrone, Debora Pirillo

|Jan 14, 2025
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells.

Stefano Miglietta, Manuela Sollazzo, Iacopo Gherardi

|Oct 25, 2024
Clinical Insights and Future Prospects: A Comprehensive Narrative Review on Immunomodulation Induced by Electrochemotherapy.

Martina Ferioli, Anna Myriam Perrone, Pierandrea De Iaco

|Sep 12, 2024
A randomized controlled trial on the oncologic outcomes of use of the intrauterine manipulator in the treatment of apparent uterine-confined endometrial carcinoma: the MANEC Trial.

Stefano Uccella, Andrea Puppo, Fabio Ghezzi

Pageof 8

Frequent Collaborators

15 joint publications

Gloria Ravegnini

11 joint publications

Antonio De Leo

8 joint publications

Martina Ferioli

7 joint publications

Alessio Giuseppe Morganti